Search

Search Constraints

You searched for: Author/Creator Roffler, Steve R.

Search Results

1. A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor. (26th November 2021)

2. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus. (1st October 2016)

3. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus. (1st October 2016)

4. Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes. (15th July 2020)

5. Discovery of Specific Inhibitors for Intestinal E. coli  β-Glucuronidase through In Silico Virtual Screening. (9th March 2015)

10. Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer. (28th June 2019)